help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2005-0192
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
20/1/1    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, J.
Right arrow Articles by Archer, T. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, J.
Right arrow Articles by Archer, T. K.
Molecular Endocrinology 20 (1): 1-13
Copyright © 2006 by The Endocrine Society


Minireview

Changes in Attitude, Changes in Latitude: Nuclear Receptors Remodeling Chromatin to Regulate Transcription

Jianguang Chen, H. Karimi Kinyamu and Trevor K. Archer

Chromatin and Gene Expression Section, Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, National Institutes of Health, Research Triangle Park, North Carolina 27709

Address all correspondence and requests for reprints to: Trevor K. Archer, Chromatin and Gene Expression Section, Laboratory of Molecular Carcinogenesis, National Institute of Environmental Health Sciences, 111 Alexander Drive, P.O. Box 12233 (MD E4-06), Research Triangle Park, North Carolina 27709. E-mail: archer1{at}niehs.nih.gov.


    ABSTRACT
 TOP
 ABSTRACT
 NUCLEAR RECEPTORS (NRs)
 ATP-DEPENDENT CHROMATIN...
 ATP-DEPENDENT CHROMATIN...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
Nuclear receptors (NRs) are a large family of ligand-dependent transcription factors that regulate important physiological processes. To activate or repress genes assembled naturally as chromatin, NRs recruit two distinct enzymatic activities, namely histone-modifying enzymes and ATP-dependent chromatin remodeling complexes, to alter local chromatin structure at target gene promoters. In this review, we examine the functional relationship between ATP-dependent chromatin remodeling complexes and NRs in the context of transcriptional regulation. Using the steroid-responsive mouse mammary tumor virus promoter as a model system, we discuss in detail the molecular mechanisms underlying the recruitment of these complexes and subsequent chromatin structure changes catalyzed by this group of enzymes. In addition, we extend the discussion to other NR-regulated promoters including the pS2 promoter. Finally, we summarize specific principles governing this critical relationship, identify unanswered questions and discuss the potential application of these principles in rational drug design.


    NUCLEAR RECEPTORS (NRs)
 TOP
 ABSTRACT
 NUCLEAR RECEPTORS (NRs)
 ATP-DEPENDENT CHROMATIN...
 ATP-DEPENDENT CHROMATIN...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
NRs ARE A LARGE family of ligand-dependent transcription factors. They regulate important physiological processes including but not limited to reproduction, metabolism, development, and homeostasis (1). NRs bind their cognate DNA sequences and modulate gene expression within target tissues (2). These receptors can be subdivided into three major classes (3). Class I receptors are the classic steroid hormone receptors, which upon ligand activation bind inverted repeat DNA sequences (hormone response elements) as homodimers. This class includes receptors for estrogen (ER), progestins (PR), glucocorticoid (GR), androgens (AR) and mineralocorticoid. In the absence of ligand, class I NRs are sequestered in complexes with heat shock proteins and are transcriptionally inactive. Class II NRs bind to their cognate DNA sites in the absence of ligand. They often form heterodimers with other members of this class, usually 9-cis retinoic acid retinoid X receptor. Receptors for thyroid hormone (TR), vitamin D (VDR), all-trans retinoic acid and the peroxisome proliferator-activated receptor (PPAR) belong to this class of NRs. The class III NRs are termed "orphan receptors" because their ligands are currently unknown. This family includes ER-related receptors, testis receptors (TR2 and R4) and many others (4).

All members of the NR super family share a signature modular domain structure, which consists of an amino-terminal transcriptional activation function (AF1) domain, a conserved zinc-finger DNA binding domain, a hinge region and a carboxyl-terminal ligand binding domain that overlaps with a second transcriptional AF2 domain. Whereas the AF1 activity is constitutively active in most cell types, the AF2 activity is ligand dependent (5).

Chromatin
Within the eukaryotic nuclei, DNA is complexed with histones to form a dynamic polymer termed chromatin (6). The fundamental structural unit of chromatin is the nucleosome which consists of approximately 146 bp of DNA wrapped around an octamer of histones containing two copies each of four core histone proteins: H2A, H2B, H3, and H4 (7). In addition to the four core histones, a fifth class of histone, the linker histone H1, associates with DNA between nucleosomes and may facilitate the formation of higher order chromatin organization such as chromatin fibers (8). Packaging genomic DNA into chromatin presents a significant physical barrier for regulatory proteins such as transcription factors to access their DNA target sites (9). However, unlike many transcription factors, some NRs are capable of binding to their hormone response DNA elements (HRE) embedded in chromatin (10). Upon ligand activation, NRs bind to HRE and recruit many transcriptional cofactors including chromatin remodeling factors to the target gene promoters. The chromatin remodeling activities recruited by NRs alter the local chromatin structure and allow other essential transcription factors to bind and activate or repress transcription (11, 12).

Chromatin Remodeling Factors
Two distinct classes of chromatin remodeling protein complexes have been identified. The first class is ATP-dependent complexes that are capable of directly changing the chromatin structure. They use the energy derived from ATP hydrolysis to alter the position and/or stability of nucleosomes in a noncovalent manner (13). The ATP-dependent chromatin remodeling complexes contain a core ATPase catalytic subunit that belongs to the Swi2/Snf2 superfamily of DNA helicases (14). To this date, five major families of ATP-dependent remodeling machines have been described based on the identity of their distinct ATPase subunits, including SWI/SNF, ISWI, Mi-2/NuRD, INO80, and SWR1 (15). Among them, the SWI/SNF family was the first to be discovered and since then has been the best characterized with regard to structure, function, and enzymatic activity.

The second class of chromatin remodeling complex consists of the histone modifying enzymes including histone acetyltransferases, histone deacetylases (HDACs), histone methyltransferases, kinases, and ubiquitin ligases that catalyze various posttranslational modifications of histone such as acetylation, phosphorylation, methylation, and ubiquitination (16). Current experimental evidence supports the notion that histone modifications are epigenetic markers that facilitate the recruitment of chromatin binding proteins to dictate a distinct chromatin structure (histone code hypothesis) (17). Because the role of histone modifications in transcriptional regulation has been the subject of several recent reviews, we will discuss it here only briefly (16, 18). In this review, we focus our attention on the ATP-dependent chromatin remodeling complexes, with an emphasis on their established and putative roles in NR-mediated transcriptional regulation.


    ATP-DEPENDENT CHROMATIN REMODELING COMPLEXES
 TOP
 ABSTRACT
 NUCLEAR RECEPTORS (NRs)
 ATP-DEPENDENT CHROMATIN...
 ATP-DEPENDENT CHROMATIN...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
SWI/SNF Family
The SWI/SNF family of proteins was first identified in yeast through genetic screens searching for genes that are required for mating type switching (SWI) and sucrose nonfermenting (SNF) (19, 20). Further screening of suppressing mutations of SWI/SNF phenotypes resulted in isolation of genes encoding histones or other chromatin-associated proteins, suggesting that SWI/SNF proteins regulate transcription by relieving the repressive effects of chromatin (21). The yeast SWI/SNF proteins were later found to form a multisubunit complex termed SWI/SNF complex (22). Biochemical characterization of the complex revealed that yeast SWI/SNF complex alters nucleosomal structure and increases the accessibility of proteins to DNA templates assembled as chromatin in an ATP-dependent manner in vitro (23). The ATPase activity of SWI/SNF complex is provided by the Swi2/Snf2 subunit. In addition to a conserved ATPase domain, the Swi2/Snf2 ATPase also contains the bromodomain, a motif capable of binding acetylated lysine residues in histones (24). In yeast, there is a second, more abundant SWI/SNF-like complex called RSC complex (remodels the structure of chromatin) (25). The RSC complex contains the Swi2/Snf2-like ATPase protein Sth1 as the core ATPase and possesses similar biochemical activities on chromatinized DNA template in vitro (26). Whereas the SWI/SNF complex is dispensable for yeast growth in normal laboratory conditions, the RSC complex is essential for mitotic growth of yeast, suggesting that in vivo these two complexes control the expression of unique set of genes (25).

Orthologs of SWI/SNF complexes closely related to those characterized in yeast were subsequently discovered in humans and Drosophila (27, 28). The Brahma protein or Brm is the only Drosophila ortholog of yeast Swi2/Snf2 ATPase and functions as the catalytic ATPase in Drosophila SWI/SNF like Brm complex (27). The Brm gene was first identified as a suppressor for the polycomb (Pc) mutation (29). Polycomb family proteins are transcriptional repressors and there is evidence to suggest that Pc family proteins repress transcription by facilitating the formation of a repressive, hetero-chromatin-like structure (29). Therefore, the Brm complex presumably antagonizes Pc family protein activity and activates transcription by loosening the chromatin structure (29). The Brm complex has also been shown to be important for homeotic genes expression in Drosophila development and deletion of Brm gene is embryonic lethal (30).

The human genome contains genes encoding two yeast Swi2/Snf2 orthologs: the human Brm protein (hBrm) and the Brm-related gene 1 protein (BRG1) (31, 32). The human SWI/SNF complex contains either BRG1 or hBrm as the catalytic ATPase subunit and approximately 10–12 BRG1-associated factors (BAFs) as accessory factors (33). The human SWI/SNF complex is heterogeneous in terms of subunit composition. Most of the purified complexes contain subunits BAF170, BAF155, BAF60, BAF57, BAF53, and BAF47 (IN1/SNF5) besides BRG1 or hBrm (28). In addition, many other proteins including histone-modifying enzymes HDAC1/2, protein arginine methyltranferase 5, coactivator-associated arginine methyltransferase 1 (CARM1), transcription corepressor mSin3A, and tumor suppressor BRCA1 have been shown to copurify with human SWI/SNF complex when different purification schemes are used (34). The minimal catalytic core required for efficient chromatin remodeling in vitro consists of four subunits: BRG1, BAF155, BAF170, and BAF47 although BRG1 alone possesses some remodeling activity (35). BAF155 and BAF170 are highly homologous and probably form a heterodimer in the complex (33). In some tissues, either BAF155 or BAF170 is predominantly expressed and a homodimer may be formed (36). In humans, there are three BAF60 genes encoding three highly homologous proteins termed BAF60a, BAF60b, and BAF60c (33). Whereas BAF60a and BAF60b are expressed in many tissues, BAF60c is expressed mostly in the heart and muscle, suggesting a tissue-specific role for this subunit (37, 38). Two additional BAF subunits, BAF250 and BAF180, are present mutually exclusively in human SWI/SNF complex. The human BAF180-containing SWI/SNF complex (termed P-BAF complex) is proposed to be more related to the yeast RSC complex than the BAF250-containing human SWI/SNF complex (also known as BAF complex) in terms of subunit composition as BAF180 is homologous to three RSC-specific subunits (Rsc1, Rsc2, and Rsc4) (39, 40). The P-BAF complex has been shown to localize to kinetochores of mitotic chromosomes. The P-BAF, but not BAF complex, was able to support vitamin D receptor-dependent gene activation on a chromatinized template in vitro, suggesting a functional difference between these two variant SWI/SNF complexes. However, either BAF or P-BAF complex can support GR-dependent activation of the mouse mammary tumor virus promoter in vivo (41). Recently, the phenotype of BAF180 knockout mouse was reported (42). Deletion of BAF180 gene in mouse results in severe hypoplastic ventricle development and trophoblast placental defects. Because the expression of BAF250 and other BAF complex subunits are not affected in BAF180 null mice, these results indicate a BAF180/P-BAF complex-specific function in vivo. In the same study, a group of BAF180-regulated genes in the developmental heart was also identified by microarray analysis; however, it is not known currently whether these genes represent bona fide BAF180/P-BAF-specific targets.

The BRG1 and Brm-based complexes have slightly different chromatin remodeling activities in vitro, particularly when assayed with mononucleosome templates (43). In vivo, the two complexes may have quite distinct biological functions. Targeted disruption of BRG1 results in very early embryonic death in mouse, whereas Brm null mice are viable and fertile, although embryonic fibroblasts derived from these mice exhibit aberrant cell cycle regulation (44, 45). Indeed, recent in vitro and cellular studies indicated that Brm, rather than BRG1, was usually recruited to cell cycle regulated gene promoters (43). Targeted deletion of BAF155 subunit in mouse is also embryonic lethal (46). However, neither BRG1 nor hBrm seems to be critical for fundamental cellular functions because cells such as the human adrenal adenocarcinoma SW13, which lack both BRG1 and hBrm, survive in tissue culture (47).

The nature of the remodeled chromatin state generated by SWI/SNF complex has been extensively studied in vitro (13). Using in vitro assembled chromatin template and either purified SWI/SNF complex or the ATPase subunit alone, it was demonstrated that the SWI/SNF complex increases the mobility of the nucleosomes on DNA templates. When the mobility of a nucleosome is physically restrained, SWI/SNF complex can create a DNA loop or twist on the surface of the nucleosome. The remodeled state generated by SWI/SNF is not a static one but a mixture of several distinct nucleosome states. The energy derived from ATP hydrolysis is used to transiently disrupt DNA-nucleosome interactions (48). These observations provide a mechanistic explanation for the increased accessibility of nucleosome DNA to regulatory factors after remodeling by SWI/SNF.

ISWI Family
The ISWI (Imitation of SWI) family of ATP-dependent chromatin remodeling complexes consists of a group of heterogeneous complexes all containing the ISWI ATPase as the catalytic core (49). In addition to the highly conserved ATPase domain, the ISWI protein contains a SANT (SW13, ADA2, N-CoR, and TFIIB) domain, a potential nucleosome interaction module (50). The ISWI-based complexes were initially purified from Drosophila and at least three ISWI complexes are known in Drosophila: the NURF (nucleosome-remodeling factor) complex, the ACF (ATP-utilizing chromatin assembly and remodeling factor) complex and the CHRAC (chromatin assembly complex) complex (51). Each complex displays different accessory subunits and may have distinctive functions. The human genome encodes two ISWI orthologs, namely SNF2H and SNF2L. SNF2H is the catalytic subunit of numerous protein complexes biochemically purified from human cells. They include the hACF/WCRF (Williams syndrome transcription factor-related chromatin remodeling factor) complex, the WICH (Williams syndrome transcription factor-ISWI chromatin remodeling complex) complex, the RSF (remodeling and spacing factor) complex, the NoRC (nucleosome remodeling complex) complex, the huCHRAC complex, and the SNF2H-cohesin complex (51). In vitro, most of ISWI-based complexes have nucleosome spacing activity that results in the formation of regularly ordered nucleosome arrays (52).

Genetic studies in Drosophila suggest that ISWI based complexes can activate gene expression both in vitro and in vivo (53). However, the observation that ISWI is preferentially associated with transcriptionally silent chromatin regions in Drosophila polytene chromosome suggests that in vivo ISWI is primarily involved in transcriptional repression and gene silencing (54). The role of human ISWI based complexes in transcriptional regulation has not been extensively studied. Recently, it was found that human SNF2L is the catalytic core of a newly purified human NURF like complex that facilitates the transcriptional activation of human Engrailed, a homeodomain protein that regulates neuronal development in the brain (55).

Mi-2/NuRD Family
The Mi-2/NuRD (nucleosome remodeling and deacetylase) complexes are also highly heterogeneous in subunit composition but they all contain the dermatomyositis-specific autoantigen Mi-2 as the core ATPase (56). The Mi-2 protein contains the chromodomain, a potential methyl-lysine binding motif (57). In humans, there are two Mi-2 genes coding for two homologous proteins, namely Mi-2{alpha} and Mi-2ß (58). In addition to the Mi-2{alpha} or Mi-2ß ATPase, the complex also contains the histone modification enzyme HDAC1/2, methylated DNA binding proteins, histone H4-interacting protein RbAp46/48, and members of metastasis-associated protein gene family MTA1, MTA2, and MTA3 (56). The presence of histone-modifying enzymes in Mi-2 complex provides a unique link between Mi-2/NuRD complex and histone modification enzymes. The MTA proteins were first discovered due to their increased expression in metastatic breast cancer tissues (59). The three MTA proteins exist mutually exclusively in the Mi-2 complexes (60). Because both HDAC activity and methylated DNA are usually associated with gene repression and silencing, it is not surprising that Mi-2/NuRD complex has been involved predominantly in transcriptional repression (56).

INO80 Family and SRW1 Family
Search of the yeast genome for genes encoding proteins containing the conserved ATPase domain of Swi2/Snf2 identified two new members of the Swi2/Snf2 superfamily: the INO80 protein and SWR1 protein (61, 62). Biochemical purification revealed that both INO80 and SWR1 are the ATPases of distinct multisubunit complexes. Limited data suggest that INO80 based complexes are involved in transcriptional activation and DNA damage repair in yeast (61, 63). The SWR1-based complex is responsible for the incorporation of the histone H2A variant H2A.Z into nucleosome in a replication-independent manner (62). Histone H2A.Z is enriched at the border of heterochromatin and euchromatin in yeast and may play a role in suppressing the spread of heterochromatin (64). Thus, it appears that SWR1 complex may help establish and/or maintain transcriptionally competent chromatin domains within yeast genome. Although both the INO80 and SWR1 protein have orthologs in mammals, no biochemical characterization or functional study has been carried out on the putative mammalian INO80 or SWR1 complexes (34).


    ATP-DEPENDENT CHROMATIN REMODELING COMPLEXES AND NR-MEDIATED TRANSCRIPTIONAL REGULATION
 TOP
 ABSTRACT
 NUCLEAR RECEPTORS (NRs)
 ATP-DEPENDENT CHROMATIN...
 ATP-DEPENDENT CHROMATIN...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
A role for SWI/SNF complex in steroid receptor-dependent transcriptional regulation was first proposed for GR in yeast studies and later substantiated in mammalian cell studies (32, 65, 66). Since then, a large body of evidence has demonstrated that ATP-dependent chromatin remodeling complexes, especially the mammalian SWI/SNF complexes, affect ligand-dependent transcriptional regulation by steroid hormone receptors (12). Using model systems such as the steroid hormone-responsive mouse mammary tumor virus (MMTV) promoter or the estrogen-responsive pS2 promoter, molecular details of the process have been elucidated. In the sections that follow, we present an in-depth overview of these model systems and then discuss the knowledge gained from studying other NR-regulated cellular promoters.

Activation of MMTV Promoter by GR
When stably integrated into mammalian cells, the MMTV promoter forms an array of six positioned nucleosomes (nucleosomes A–F) over the regulatory region including the HREs (67). Nucleosomes A and B represent the hormone sensitive region encompassing four glucocorticoid response elements and binding sites for other transcription factors such as nuclear factor 1 (NF1), octamer transcription factor (Oct1), and the TATA binding protein (TBP). In the absence of hormone, the organized chromatin structure blocks the binding of transcription factors NF1, Oct1, and TBP to the promoter (Fig. 1AGo) (68). Glucocorticoid activation of the MMTV promoter is a bimodal process (69). Within 5 min of glucocorticoid treatment, GR binds to glucocorticoid response elements within chromatin and induces rapid changes in nuclear architecture at the nucleosome B region of the promoter as shown by restriction enzyme hypersensitivity assay (70). The remodeled chromatin allows NF1, OTF, and TBP to bind their respective binding sites (Fig. 1CGo). This series of events, initiated by the GR binding on the promoter, eventually leads to formation of the preinitiation complex and activation of the MMTV promoter (Fig. 1DGo) (71). In contrast, a transiently transfected MMTV promoter does not adopt an organized nucleosome structure and allows the binding of NF1 in the absence of glucocorticoids (69, 72).



View larger version (42K):
[in this window]
[in a new window]
 
Fig. 1. GR-Mediated Activation of MMTV Promoter Organized as Chromatin in Vivo

Before hormone exposure, nucleosome structure at the MMTV promoter blocks the binding of NF1, OTFs, and general transcription factors (GTFs) including TBP (A). Upon hormone treatment, GR binds its site on the nucleosome and recruits BRG1 complex through BAF60a, BAF250 or BAF57 with concurrent loss of histone H1 (B). The BRG1 complex remodels the nucleosome structure and allows the binding of NF1, OTFs, and other cofactors (CoFs) (C). In vitro, GR is found to leave the promoter at this step but in vivo evidence has not been obtained. The binding of all these factors lead to recruitment of GTFs and RNA polymerase II to form a stabilized preinitiation complex (PIC) (D). Prolonged hormone treatment leads to dephosphorylation of histone H1and the promoter becomes refractory to GR activation (E). Currently, it is not known how the activation process is terminated and the promoter returns to its prehormone state after hormone withdrawal (A).

 
Compelling experimental evidence supports the view that GR-mediated chromatin remodeling at the MMTV promoter is dependent on the BRG1 complex (Fig. 1BGo) (41, 66). First, type II antiprogestins can inhibit GR-induced remodeling and activation of MMTV promoter in T47D cells, but the inhibition is reversed by overexpression of BRG1 protein in these cells, suggesting that PR and GR compete to recruit BRG1 to the MMTV promoter (66). Secondly, GR can coimmmunoprecipitate with BRG1 complex components in the presence of hormone, suggesting a physical interaction between GR and BRG1 complex. Experiments using a stably integrated MMTV promoter in the BRG1/Brm null SW13 cells further demonstrated unequivocally that GR-induced chromatin remodeling at the MMTV promoter is solely dependent on BRG1 complex. Neither ISWI nor Mi-2 based remodeling complexes are able to substitute for the BRG1 complex in remodeling of MMTV chromatin (41). In the same study, it was also shown that the ATPase activity of BRG1 is essential for its remodeling function. Recently, data from this and other laboratories provided additional insights into the nature of GR-initiated recruitment of the BRG1 complex to the MMTV promoter. Using MMTV promoter assembled as chromatin in vitro, it was demonstrated that the recruitment of BRG1 by GR is transient as the remodeling event actually leads to displacement of GR from the promoter (73). Because the cycling of GR has been observed on MMTV promoter in vivo (74), these results suggest a role for BRG1 complex in GR cycling on MMTV promoter. In addition, chromatin immunoprecipitation (ChIP) assay showed that GR and BRG-1 cannot stably associate with MMTV promoters in vivo in the absence of NF1 binding (72). This observation raises the possibility that chromatin structure is not a passive landing site for transcription factors but by combinatorial and cooperative mechanisms defines a range of potential responses (75). These results point to a dynamic rather than a static relationship between GR binding, chromatin remodeling and NF1 binding on the MMTV promoter (76).

The interaction of GR with BRG1 complex appears to be mediated by at least two subunits of this complex (Fig. 1BGo) (40, 77). GR interacts with BAF60a independent of GR ligand status (77). The GR-BAF60a interaction is required for efficient GR transactivation and chromatin remodeling at the MMTV promoter in vivo. Expression of a dominant-negative form of BAF60a disrupts GR and BRG1 complex interaction and leads to decreased chromatin remodeling and MMTV activation (77). In contrast, GR interacts with BAF250 in a ligand-dependent manner (40). BAF250 has also been shown to potentiate the transcriptional activity of GR in transient transfection assays (78). However, BAF250 seems to be dispensable for GR-mediated chromatin remodeling at the MMTV promoter given that the remodeling process takes place efficiently in the BAF250-negative, BAF180-positive T47D cells (79). Surprisingly, BAF180 is also not required for GR-induced chromatin change at the same promoter because the BAF250-positive, BAF180-negative SW13 cells support the remodeling process as long as BRG1 is present (41). Given the fact that BAF250 and BAF180 are the signature components of the BAF and P-BAF complexes, respectively, these results suggest that GR may not discriminate between BAF and PBAF complexes and can use either one of them to remodel chromatin.

Further insights into the mechanisms by which the GR and SWI/SNF cooperate to alter chromatin structure came from recent experiments that investigated the function of the ATPase subunit in the complex (80). In this study, the ATPase domains were swapped between BRG1 and hSNF2L and the activities of resultant chimeras were evaluated in vitro and in vivo. In vitro chromatin remodeling assays revealed that both chimeras were active but surprisingly, the source of the ATPase domain determined the mechanism of remodeling (13, 80). Both wild-type BRG1 and the BRG1/hSNF2L-ATPase chimera were active in vivo as evidenced by the profiles of genes induced when introduced into cells lacking BRG1. However, with respect to GR-mediated activation the chimera was unable to substitute for the wild-type BRG1 in transcriptional activity or chromatin remodeling assays, demonstrating that BRG1 and ISWI ATPase domains are not functionally interchangeable in vivo.

Activation of MMTV Promoter by Other Steroid Hormone Receptors
The MMTV promoter can also be activated by progestins, androgens, and mineralocorticoids (12). An initial report suggested that an ISWI-based complex is responsible for PR-induced chromatin remodeling in vitro (81). However, recent studies indicated that BRG1 complex, rather than ISWI complex, plays a critical role in chromatin remodeling and transcriptional activation by these receptors. In one study, the PR competes with the GR for the BRG1 complex in T47D breast cancer cells treated with dexamethasone in the presence of type II antiprogestins, suggesting that BRG1 is required for PR-dependent activation of MMTV promoter (66). In another study, ChIP analysis in T47D cells demonstrated that BRG1 is recruited to the MMTV promoter by ligand bound PR in these cells, again supporting a role for BRG1 in PR-dependent activation of the promoter (82).

BRG1 is also involved in AR-dependent chromatin remodeling and activation of the MMTV promoter. Studies aimed at dissecting the molecular mechanism of AR recruitment of BRG1 complex have employed the MMTV promoter assembled as chromatin in Xenopus oocytes as a model system (83). In this case, BRG1 is recruited to the MMTV promoter in the presence of the AR ligand R1881. In addition, ligand-dependent activation of the MMTV promoter by AR is impaired in SW13 cells, supporting a role for BRG1 complex in AR-dependent activation of MMTV promoter (83). However, in contrast to GR, a direct interaction between AR and BRG1 complex was not detected by coimmunoprecipitation assay in this study. In fact, the recruitment of BRG1 complex seems to be dependent on the p160 family of steroid hormone receptor coactivators and the histone acetyltransferase cAMP response element binding protein-binding protein (CBP).

The precise nature of GR- and PR-induced chromatin remodeling, as assessed by nuclease accessibility, remains unclear at this point. That it mostly occurs at the nucleosome B region in vivo is more consistent with a DNA looping out vs. sliding mechanism (13). An in vitro study suggested GR can induce rearrangement of the histone octamer at the nucleosome B region without measurable loss of histones (73). In addition, previous studies from our laboratory have shown that in human breast cancer cells, PR-mediated increases in MMTV transcription can occur in the absence of any structural rearrangement of the promoter as measured by restriction enzyme hypersensitivity assay (84). However, a recent report has provided some evidence to argue for a loss of histone H2A/H2B dimers on the MMTV promoter upon PR-mediated activation in a SWI/SNF complex-dependent manner (85). Currently, it is not known whether the seemingly divergent observations on the same promoter are receptor dependent or perhaps due to different experimental systems used in the studies. However, the availability of purified and well-characterized reagents and well-defined chromatin targets should allow these issues to be resolved.

Activation of pS2 Promoter by ER
The human pS2 gene promoter is estrogen responsive and the HRE as well as TATA box sequence are covered by two precisely positioned nucleosomes in human mammary epithelial cells (Fig. 2AGo) (86). The nucleosome structure blocks TBP binding to the TATA box (87). In MCF7 cells with endogenous ER, estrogen treatment induced two major deoxyribonuclease I (DNase I)-hypersensitive sites, one of which is located in the proximal promoter, suggesting the formation of an open chromatin structure in response to ligand (87).



View larger version (28K):
[in this window]
[in a new window]
 
Fig. 2. Activation of the pS2 Promoter by ER in Vivo

ER activation of the pS2 promoter is a cycling process. Before hormone treatment, ERE and TATA box at the pS2 promoter are located within two promoter proximal nucleosomes (A). Upon hormone treatment, ER binds to the ERE and recruits BRG1 complex to remodel the nucleosome structure (B). The open structure allows binding of multiple CoFs, general transcription factors (GTFs) and RNA polymerase II to initiate transcription (C). After RNA polymerase II leaves the promoter, HDAC-BRG1/Brm complex is recruited to the promoter, ER is released and the ERE bearing nucleosome adopts a closed structure (D). At this stage, the TATA bearing nucleosome remains open and GTFs still bind to the promoter with a different set of CoFs being recruited to the promoter. The semiopen promoter can either become full open again by ER binding and permit next round of transcription (a short-cut cycle), or, by recruiting Mi-2/NuRD complex and yet another set of CoFs (E), returns to full closed state, which can be activated by liganded ER (the full cycle).

 
Extensive ChIP analysis has revealed molecular details of ER activation of pS2 promoter in MCF7 cells (88). During its activation, ER{alpha} binds to and leaves the promoter in a cycling manner. The cyclic turnover of ER{alpha} on pS2 promoter is dependent on proteasome-mediated degradation of liganded receptor and has been suggested as a mechanism for allowing cells to respond continuously to changes in extracellular hormone concentration (89). A large number of transcription factors and cofactors including ATP-dependent chromatin remodeling complexes are sequentially recruited to pS2 promoter by liganded ER. The BRG1 complex is the first of these enzymatic factors to be recruited by ER{alpha}, followed by the p160 family of steroid receptors coactivators, histone-modifying enzymes, or general transcription factors (Fig. 2Go, B and C). Interestingly, BRG1 but not Brm complex is recruited at this stage, suggesting a specific requirement for a BRG1 based complex. The BRG1 complex presumably generates a permissive chromatin structure to allow other factors to bind. Near the end of this initial activation process, BRG1 or Brm complex containing HDAC is recruited to the promoter to facilitate promoter clearance and ER departure from the promoter (Fig. 2DGo). After ER{alpha} and the general transcription factors including TBP leave the promoter, Mi-2/NuRD complex is recruited by an unknown mechanism to generate a repressive chromatin structure within the pS2 promoter (Fig. 2EGo). As such, at least two distinct ATP-dependent chromatin remodeling complexes participate in this process. Whereas the Mi-2/NuRD complex is only involved in reestablishing a repressive state of the pS2 promoter, the BRG-1 complex has a dual role: opening chromatin to allow transcription factors to bind and terminating transcription via receptor clearance (88). ChIP analysis also demonstrated that BRG1 is recruited to several other endogenous ER{alpha}-responsive promoters in vivo (90). Because chromatin structure at these promoters has not been fully characterized, under the experimental conditions used for the ChIP assays, the structural impact of BRG1 mediated remodeling on these promoters is not clear. Importantly, the BRG1 complex subunit BAF57 interacts with the ER and enhances ER{alpha}-dependent transcriptional activation on pS2 promoter (91). This result may imply that ER recruits BRG1 complex through the BAF57 subunit although the evidence is indirect.

Receptor-Dependent and Promoter-Specific Recruitment of ATP-Dependent Chromatin Remodeling Complexes
Although not as extensively studied as the GR and ER{alpha}, many other NRs use ATP-dependent chromatin remodeling complexes to regulate transcription. In contrast to GR activation of MMTV promoter, which does not distinguish between BAF and P-BAF complexes, the VDR specifically requires P-BAF complex (92). In vitro transcription assays using a chromatinized artificial VDR-responsive promoter and purified remodeling complexes indicated that P-BAF complex is essential for VDR to activate promoter embedded in chromatin. Neither the highly analogous BAF complex nor the ISWI-based ARF complex can support transcriptional activation by VDR (92). Interestingly, biochemical purification of proteins associated with VDR in a ligand-dependent manner resulted in isolation of a variant human SWI/SNF complex termed WINAC complex, which contains the Williams syndrome transcription factor (WSTF) and elongation factors in addition to the core subunits of human SWI/SNF complex (93). Surprisingly, neither the P-BAF complex-specific BAF180 nor human ISWI complex components were found in this complex. Chromatin-immunoprecipitation and transient transfection assays indicated that this complex is recruited to VDR-responsive promoters and essential for VDR-mediated transcriptional regulation. Defects in this complex negatively affect VDR signaling and account for at least some phenotypes of Williams syndrome, a rare autosomal genetic disease. Recently, BAF60a and BAF60c, two homologous subunit of human SWI/SNF complex, have been shown to differentially interact with several NRs (37, 77, 94). For example, BAF60c but not BAF60a interacts with PPAR{gamma}. Transient transcription assays indicated that BAF60c enhances PPAR{gamma}-mediated transcriptional activation of its target promoters. This observation suggests that PPAR{gamma} specifically recruits BAF60c containing SWI/SNF complex to activate gene expression (37).

A role for Mi-2/NURD complex in repressing NR-dependent transcription was first suggested by a study showing that the corepressor Krab-associated protein 1 (KAP-1), together with HDAC-1/2 and SWI/SNF are components of the NR corepressor complex (NCoR) (95). KAP-1 has been shown to associate with an isoform of Mi-2{alpha} protein, an integral component of the Mi-2/NURD complex (96). In another study using artificial thyroid hormone-responsive promoter assembled as chromatin in Xenopus oocytes, the Mi-2/NuRD complex was found to associate with this promoter independent of thyroid hormone receptor status (97), suggesting a global transcription repression function for the Mi-2/NuRD complex. In contrast to TR, however, a direct interaction between ER and the MTA1 subunit of Mi-2/NuRD complex has been demonstrated (98). ER can recruit MTA1-containing Mi-2/NuRD complex to its target promoters, and lead to down-regulation of ER{alpha} transcriptional activity. Recently, the Mi-2ß subunit was shown to directly interact with the retinoid-related orphan receptor {gamma} (ROR{gamma}) and suppress ROR{gamma} activity in a transient transfect assay (99). Taken together, these observations support the hypothesis that Mi-2 has both promoter-specific repression activity and a global gene silencing function.

A differential requirement for human SWI/SNF complex in AR-mediated transactivation was revealed in studies using two AR activated promoters, prostate-specific antigen (PSA) and probasin (100). Like in the case of MMTV promoter, AR activation of PSA is strictly dependent on SWI/SNF complex. Furthermore, BAF57 has been shown to directly interact with AR and is responsible for AR-dependent recruitment of SWI/SNF complex to the PSA promoter and gene activation (101). In contrast, SWI/SNF activity is not absolutely required for activating the probasin promoter. These results clearly indicate that the requirement for a specific chromatin remodeling complex in activation of AR-responsive genes is dependent on promoter architecture.

The Interplay between ATP-Dependent Chromatin Remodeling Complexes and Histone Modifying Enzyme
The presence of protein motifs recognizing histone modifications in some subunits of ATP-dependent chromatin remodeling complex implicates an intimate functional relationship between ATP-dependent remodeling complexes and histone modifying enzymes (14). This relationship is illustrated in several NR-mediated gene activation processes. The occupation of MMTV promoter by cAMP response element binding protein-binding protein (CBP)/p300 histone acetyltransferases appears to be a prerequisite for subsequent recruitment of BRG1 complex to this promoter in Xenopus oocyte (83). In addition, the presence of bromodomain in the BRG1 protein suggests that acetylated lysines may strengthen BRG1 complex binding to this promoter, although acetylated lysines alone are not sufficient for recruiting BRG1 complex (83). In the case of Mi-2 complex, the existence of HDACs in this complex suggests that histone deacetylation is inherently connected to Mi-2/NuRD-mediated chromatin remodeling. Finally, functional and mechanistic links between histone arginine methylation and ATP chromatin remodeling have been uncovered in a recent study showing association of CARM1, a histone arginine methyltransferase, with BRG1 complex components in a novel complex termed NUMAC (nucleosomal methylation activator complex) (102). In this complex, the histone methyltransferase activity of the NUMAC complex on nucleosomal histones is much higher than that of purified CARM1 alone. In addition, CARM1 stimulates the ATPase activity of BRG1. Therefore, CARM1 and BRG1 enhance each other’s enzymatic activity by forming the NUMAC complex. As a result, NUMAC complex may support ER-mediated transcriptional activation more efficiently when compared with isolated CARM1 protein or SWI/SNF complex alone (102).

Histone H1 can stabilize the nucleosome structure by limiting the mobility of nucleosomes. Phosphorylation status of histone H1 on the MMTV promoter is intimately linked to the ability of GR to activate the promoter (103). Upon prolonged hormone treatment, the promoter becomes refractory to hormone induction. This refractory state is correlated with a global dephosphorylation of histone H1 and reformation of the repressive chromatin structure at MMTV promoter (Fig. 1EGo). Removal of hormone restores the transcriptional competence of the MMTV promoter and reappearance of phosphorylated histone H1 accompanies this reactivation. The decreased activation upon prolonged hormone treatment is unique to the chromatin MMTV promoter because the transiently transfected MMTV promoter is not affected (103). Prolonged hormone treatment leads to a selective dephosphorylation of specific histone H1 isoforms (104). The mechanism for histone H1 de-phosphorylation induced by long-term glucocorticoid treatment is not known, and one possibility is that the hormone inhibits a histone H1 kinase either directly or indirectly (103). The cdc2/cyclin B and cdk2 kinases have been shown to phosphorylate histone H1 in vitro (105). Cdk2 is most likely the enzyme responsible for phosphorylation of histone H1 in GR-mediated transactivation of the MMTV promoter (105). Indeed, Cdk2-specific inhibitors can block GR-mediated transcriptional activation of the promoter and mimic the inhibitory effect of prolonged glucocorticoid treatment (105).

Modulation of Subunit Composition of ATP-Dependent Chromatin Remodeling Complex in NR-Mediated Transcription
As argued above, an ATP-dependent chromatin remodeling complex can achieve functional specificity by incorporation of highly specific subunits. Results from several recent studies suggest that NRs exploit this mechanism to influence transcription through regulating the expression of specific subunits. For example, the MTA3 subunit of Mi-2/NuRD complex was found to be positively regulated by estrogen in MCF-7 cells (106). The MTA3 but not MTA2 or MTA1 containing Mi-2/NuRD complex is then recruited to the promoter of transcription repressor snail, a master regulator of epithelial to mesenchymal transitions, to repress snail expression (60). Thus, estrogen signaling determines the metastasis potential of breast cancer cells by controlling snail expression through an indirect mechanism. Likewise, other transcription factors or signaling pathways can also exploit this mechanism to affect NR signaling. For example, MTA1 expression can be up-regulated by heregulin, an activator of the heregulin/HER2 pathway (98). The recruitment of MTA1-containing Mi-2/NuRD complex by ER{alpha} to its target genes leads to diminished ER transactivation activity. Therefore, heregulin/HER2 signaling can antagonize ER{alpha} transcription activity by increasing MTA1 expression. In another case, the expression of mouse BAF155 is down-regulated by several signaling pathways in lymphocytes (107). Loss of BAF155 expression results in resistance to GR-mediated apoptosis in these cells. In summary, ATP-dependent chromatin remodeling complexes provide a previously unsuspected platform for cross talk between NR and other signaling pathways.


    CONCLUSIONS AND FUTURE PERSPECTIVES
 TOP
 ABSTRACT
 NUCLEAR RECEPTORS (NRs)
 ATP-DEPENDENT CHROMATIN...
 ATP-DEPENDENT CHROMATIN...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 
The critical role of ATP-dependent chromatin complexes, especially the SWI/SNF and Mi2/NuRD families, in NR-mediated transcriptional regulation has been firmly established. The molecular detail of the recruitment process and the nature of remodeling are being elucidated on model systems such as the steroid receptor-responsive MMTV promoter and pS2 promoter. NRs can recruit ATP-dependent chromatin remodeling complexes either through a direct interaction with subunits or through other secondary transcriptional cofactors (Table 1Go). The recruitment of a specific complex to a particular promoter depends on the NR and promoter architecture. So far, the SWI/SNF complex has been associated with steroid hormone receptors and nonsteroid hormone receptors, whereas the Mi-2/NuRD is mostly connected to transcriptional regulation by the ER. Recruitment of ATP-dependent chromatin remodeling complexes to the promoter can lead to an open permissive chromatin structure that allows other essential transcription factors to bind, as demonstrated by the requirement for the SWI/SNF complex-mediated chromatin remodeling on MMTV promoter. Alternatively, a closed repressive chromatin structure may be generated so that transcription factors are excluded from the promoter as a result of Mi2/NuRD complex’s remodeling activity on pS2 promoter. Whereas the principles governing the relationship between NRs and ATP-dependent chromatin remodeling complex is being established, major research challenges still lie ahead. At present, only limited knowledge is available on the chromatin architecture of many NR-responsive, physiologically and/or pathologically relevant gene promoters. Lack of this knowledge impairs a mechanistic understanding of the potentially differential requirement of ATP-dependent chromatin remodeling complex at distinct promoters by otherwise identical NRs. Furthermore, we do not yet understand the structural biology underlying the interaction between a NR and the ATP-dependent chromatin remodeling complex. Equally important, we only have limited understanding of the role of ATP-dependent chromatin remodeling complexes in NR-mediated gene repression except in the case of ER{alpha} and Mi-2/NuRD complex. Is Mi-2/NuRD complex also involved in gene repression by other steroid receptors such as GR, PR, or AR? Can SWI/SNF complex be recruited by NRs for the purpose of repression at some hormone-responsive promoters? Because yeast and human SWI/SNF complexes have been shown to mediate gene repression (108), it will not be surprising if future experiments reveal a repressive function of SWI/SNF complex in NR mediated transcriptional regulation. Finally, with two newly discovered ATP-dependent chromatin remodeling complexes (INO80 complex and SWR1 complex) and novel subunits of known complexes being discovered, it will be exciting and challenging to determine whether they are involved in NR-mediated transcriptional regulation.


View this table:
[in this window]
[in a new window]
 
Table 1. Protein Interactions Recruiting ATP-Dependent Chromatin-Remodeling Complexes to NRs

 
NR transcriptional activities are intimately involved in many disease processes, and modulation of NR activity has been used as basis for disease treatment (109). For example, antagonists of ER and AR have been used successfully in treatment of breast cancer and prostate cancer, respectively (110). Agonists for GR such as cortisol have long been used as important antiinflammation drugs (111). Because the recruitment of ATP-dependent chromatin remodeling complex is often critical for NR-mediated transcriptional regulation, this step will be an important pharmaceutical target for modulating NR activity. For instance, with a structural understanding of the interaction between GR and human SWI/SNF complex, novel GR agonists and antagonists can be designed to specifically increase or decrease the affinity between GR and human SWI/SNF complex (79). Similarly, with an in-depth understanding of the underlying molecular mechanisms of differential requirement of chromatin remodeling complexes, it is possible to design therapeutic reagents that can selectively block NR activity on some but not all responsive promoters. This level of specificity/selectivity could be essential in reducing harmful side effects often associated with NR-based drugs currently used in the clinic.


    ACKNOWLEDGMENTS
 
We thank Drs. Sayura Aoyagi, Bonnie Deroo, and Paul Wade for critical review of the manuscript.


    FOOTNOTES
 
First Published Online July 7, 2005

Abbreviations: AF, Activation function; AR, androgen receptor; BAF, BRG1-associated factor; BRG1, Brm-related gene 1 protein; CARM1, coactivator-associated arginine methyltransferase 1; ChIP, chromatin immunoprecipitation; ER, estrogen receptor; GR, glucocorticoid receptor; hBrm, human Brm protein; HDAC, histone deacetylase; MMTV, mouse mammary tumor virus; NF, nuclear factor; NRs, nuclear receptors; OTF, octamer transcription factor; Pc, polycomb; PPAR, peroxisome proliferator-activated receptor; PR, progestin receptor; PSA, prostate-specific antigen; RSC, remodels the structure of chromatin; SNF, sucrose nonfermenting; SWI, switching independent; TBP, TATA binding protein; TR, thyroid hormone receptor; VDR, vitamin D receptor.

Received for publication May 13, 2005. Accepted for publication June 27, 2005.


    REFERENCES
 TOP
 ABSTRACT
 NUCLEAR RECEPTORS (NRs)
 ATP-DEPENDENT CHROMATIN...
 ATP-DEPENDENT CHROMATIN...
 CONCLUSIONS AND FUTURE...
 REFERENCES
 

  1. Larsen PR, Kronenberg HM, Melmed S, Polonsky KS 2003 Williams textbook of endocrinology. 10th ed. Philadelphia: W. B. Saunders
  2. Tsai MJ, O’Malley BW 1994 Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu Rev Biochem 63:451–486[CrossRef][Medline]
  3. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P, Evans RM 1995 The nuclear receptor superfamily: the second decade. Cell 83:835–839[CrossRef][Medline]
  4. Xie W, Evans RM 2001 Orphan nuclear receptors: the exotics of xenobiotics. J Biol Chem 276:37739–37742[Free Full Text]
  5. McKenna NJ, O’Malley BW 2002 Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 108:465–474[CrossRef][Medline]
  6. Wolffe AP 2000 Chromatin structure and function. 3rd ed. San Diego: Academic Press
  7. Luger K 2003 Structure and dynamic behavior of nucleosomes. Curr Opin Genet Dev 13:127–135[CrossRef][Medline]
  8. Hansen JC 2002 Conformational dynamics of the chromatin fiber in solution: determinants, mechanisms, and functions. Annu Rev Biophys Biomol Struct 31:361–392[CrossRef][Medline]
  9. Felsenfeld G, Groudine M 2003 Controlling the double helix. Nature 421:448–453[CrossRef][Medline]
  10. Urnov FD, Wolffe AP 2001 Chromatin remodeling and transcriptional activation: the cast (in order of appearance). Oncogene 20:2991–3006[CrossRef][Medline]
  11. Acevedo ML, Kraus WL 2004 Transcriptional activation by nuclear receptors. Essays Biochem 40:73–88[Medline]
  12. Kinyamu HK, Archer TK 2004 Modifying chromatin to permit steroid hormone receptor-dependent transcription. Biochim Biophys Acta 1677:30–45[Medline]
  13. Fan HY, He X, Kingston RE, Narlikar GJ 2003 Distinct strategies to make nucleosomal DNA accessible. Mol Cell 11:1311–1322[CrossRef][Medline]
  14. Eisen JA, Sweder KS, Hanawalt PC 1995 Evolution of the SNF2 family of proteins: subfamilies with distinct sequences and functions. Nucleic Acids Res 23:2715–2723[Abstract/Free Full Text]
  15. Eberharter A, Becker PB 2004 ATP-dependent nucleosome remodelling: factors and functions. J Cell Sci 117:3707–3711[Free Full Text]
  16. Fischle W, Wang Y, Allis CD 2003 Histone and chromatin cross-talk. Curr Opin Cell Biol 15:172–183[CrossRef][Medline]
  17. Strahl BD, Allis CD 2000 The language of covalent histone modifications. Nature 403:41–45[CrossRef][Medline]
  18. Berger SL 2002 Histone modifications in transcriptional regulation. Curr Opin Genet Dev 12:142–148[CrossRef][Medline]
  19. Stern M, Jensen R, Herskowitz I 1984 Five SWI genes are required for expression of the HO gene in yeast. J Mol Biol 178:853–868[CrossRef][Medline]
  20. Neigeborn L, Carlson M 1984 Genes affecting the regulation of SUC2 gene expression by glucose repression in Saccharomyces cerevisiae. Genetics 108:845–858[Abstract/Free Full Text]
  21. Hirschhorn JN, Brown SA, Clark CD, Winston F 1992 Evidence that SNF2/SWI2 and SNF5 activate transcription in yeast by altering chromatin structure. Genes Dev 6:2288–2298[Abstract/Free Full Text]
  22. Peterson CL, Dingwall A, Scott MP 1994 Five SWI/SNF gene products are components of a large multisubunit complex required for transcriptional enhancement. Proc Natl Acad Sci USA 91:2905–2908[Abstract/Free Full Text]
  23. Peterson CL, Workman JL 2000 Promoter targeting and chromatin remodeling by the SWI/SNF complex. Curr Opin Genet Dev 10:187–192[CrossRef][Medline]
  24. Yang XJ 2004 Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26:1076–1087[CrossRef][Medline]
  25. Cairns BR, Lorch Y, Li Y, Zhang M, Lacomis L, Erdjument-Bromage H, Tempst P, Du J, Laurent B, Kornberg RD 1996 RSC, an essential, abundant chromatin-remodeling complex. Cell 87:1249–1260[CrossRef][Medline]
  26. Lorch Y, Zhang M, Kornberg RD 2001 RSC unravels the nucleosome. Mol Cell 7:89–95[CrossRef][Medline]
  27. Dingwall AK, Beek SJ, McCallum CM, Tamkun JW, Kalpana GV, Goff SP, Scott MP 1995 The Drosophila snr1 and brm proteins are related to yeast SWI/SNF proteins and are components of a large protein complex. Mol Biol Cell 6:777–791[Abstract]
  28. Wang W, Cote J, Xue Y, Khavari PA, Biggar SR, Muchardt C, Kalpana GV, Goff SP, Yaniv M, Workman JL, Crabtree GR 1996 Purification and biochemical heterogeneity of the mammalian SWI-SNF complex. EMBO J 15:5370–5382[Medline]
  29. Kennison JA 1995 The Polycomb and trithorax group proteins of Drosophila: trans-regulators of homeotic gene function. Annu Rev Genet 29:289–303[CrossRef][Medline]
  30. Armstrong JA, Papoulas O, Daubresse G, Sperling AS, Lis JT, Scott MP, Tamkun JW 2002 The Drosophila BRM complex facilitates global transcription by RNA polymerase II. EMBO J 21:5245–5254[CrossRef][Medline]
  31. Okabe I, Bailey LC, Attree O, Srinivasan S, Perkel JM, Laurent BC, Carlson M, Nelson DL, Nussbaum RL 1992 Cloning of human and bovine homologs of SNF2/SWI2: a global activator of transcription in yeast S. cerevisiae. Nucleic Acids Res 20:4649–4655[Abstract/Free Full Text]
  32. Muchardt C, Yaniv M 1993 A human homologue of Saccharomyces cerevisiae SNF2/SWI2 and Drosophila brm genes potentiates transcriptional activation by the glucocorticoid receptor. EMBO J 12:4279–4290[Medline]
  33. Wang W, Xue Y, Zhou S, Kuo A, Cairns BR, Crabtree GR 1996 Diversity and specialization of mammalian SWI/SNF complexes. Genes Dev 10:2117–2130[Abstract/Free Full Text]
  34. Sif S 2004 ATP-dependent nucleosome remodeling complexes: enzymes tailored to deal with chromatin. J Cell Biochem 91:1087–1098[CrossRef][Medline]
  35. Phelan ML, Sif S, Narlikar GJ, Kingston RE 1999 Reconstitution of a core chromatin remodeling complex from SWI/SNF subunits. Mol Cell 3:247–253[CrossRef][Medline]
  36. Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE 2001 Characterization of SWI/SNF protein expression in human breast cancer cell lines and other malignancies. J Cell Physiol 186:136–145[CrossRef][Medline]
  37. Debril MB, Gelman L, Fayard E, Annicotte JS, Rocchi S, Auwerx J 2004 Transcription factors and nuclear receptors interact with the SWI/SNF complex through the BAF60c subunit. J Biol Chem 279:16677–16686[Abstract/Free Full Text]
  38. Lickert H, Takeuchi JK, Von Both I, Walls JR, McAuliffe F, Adamson SL, Henkelman RM, Wrana JL, Rossant J, Bruneau BG 2004 Baf60c is essential for function of BAF chromatin remodelling complexes in heart development. Nature 432:107–112[CrossRef][Medline]
  39. Xue Y, Canman JC, Lee CS, Nie Z, Yang D, Moreno GT, Young MK, Salmon ED, Wang W 2000 The human SWI/SNF-B chromatin-remodeling complex is related to yeast rsc and localizes at kinetochores of mitotic chromosomes. Proc Natl Acad Sci USA 97:13015–13020[Abstract/Free Full Text]
  40. Nie Z, Xue Y, Yang D, Deroo BJ, Archer TK, Wang W 2000 A specificity and targeting subunit of a human SWI/SNF family-related chromatin-remodeling complex. Mol Cell Biol 20:8879–8888[Abstract/Free Full Text]
  41. Trotter KW, Archer TK 2004 Reconstitution of glucocorticoid receptor-dependent transcription in vivo. Mol Cell Biol 24:3347–3358[Abstract/Free Full Text]
  42. Wang Z, Zhai W, Richardson JA, Olson EN, Meneses JJ, Firpo MT, Kang C, Skarnes WC, Tjian R 2004 Polybromo protein BAF180 functions in mammalian cardiac chamber maturation. Genes Dev 18:3106–3116[Abstract/Free Full Text]
  43. Kadam S, Emerson BM 2003 Transcriptional specificity of human SWI/SNF BRG1 and BRM chromatin remodeling complexes. Mol Cell 11:377–389[CrossRef][Medline]
  44. Bultman S, Gebuhr T, Yee D, La Mantia C, Nicholson J, Gilliam A, Randazzo F, Metzger D, Chambon P, Crabtree G, Magnuson T 2000 A Brg1 null mutation in the mouse reveals functional differences among mammalian SWI/SNF complexes. Mol Cell 6:1287–1295[CrossRef][Medline]
  45. Reyes JC, Barra J, Muchardt C, Camus A, Babinet C, Yaniv M 1998 Altered control of cellular proliferation in the absence of mammalian brahma (SNF2{alpha}). EMBO J 17:6979–6991[CrossRef][Medline]
  46. Kim JK, Huh SO, Choi H, Lee KS, Shin D, Lee C, Nam JS, Kim H, Chung H, Lee HW, Park SD, Seong RH 2001 Srg3, a mouse homolog of yeast SWI3, is essential for early embryogenesis and involved in brain development. Mol Cell Biol 21:7787–7795[Abstract/Free Full Text]
  47. Dunaief JL, Strober BE, Guha S, Khavari PA, Alin K, Luban J, Begemann M, Crabtree GR, Goff SP 1994 The retinoblastoma protein and BRG1 form a complex and cooperate to induce cell cycle arrest. Cell 79:119–130[CrossRef][Medline]
  48. Aoyagi S, Narlikar G, Zheng C, Sif S, Kingston RE, Hayes JJ 2002 Nucleosome remodeling by the human SWI/SNF complex requires transient global disruption of histone-DNA interactions. Mol Cell Biol 22:3653–3662[Abstract/Free Full Text]
  49. Corona DF, Langst G, Clapier CR, Bonte EJ, Ferrari S, Tamkun JW, Becker PB 1999 ISWI is an ATP-dependent nucleosome remodeling factor. Mol Cell 3:239–245[CrossRef][Medline]
  50. Boyer LA, Latek RR, Peterson CL 2004 The SANT domain: a unique histone-tail-binding module? Nat Rev Mol Cell Biol 5:158–163[CrossRef][Medline]
  51. Corona DF, Tamkun JW 2004 Multiple roles for ISWI in transcription, chromosome organization and DNA replication. Biochim Biophys Acta 1677:113–119[Medline]
  52. Aalfs JD, Narlikar GJ, Kingston RE 2001 Functional differences between the human ATP-dependent nucleosome remodeling proteins BRG1 and SNF2H. J Biol Chem 276:34270–34278[Abstract/Free Full Text]
  53. Dirscherl SS, Krebs JE 2004 Functional diversity of ISWI complexes. Biochem Cell Biol 82:482–489[CrossRef][Medline]
  54. Deuring R, Fanti L, Armstrong JA, Sarte M, Papoulas O, Prestel M, Daubresse G, Verardo M, Moseley SL, Berloco M, Tsukiyama T, Wu C, Pimpinelli S, Tamkun JW 2000 The ISWI chromatin-remodeling protein is required for gene expression and the maintenance of higher order chromatin structure in vivo. Mol Cell 5:355–365[CrossRef][Medline]
  55. Barak O, Lazzaro MA, Lane WS, Speicher DW, Picketts DJ, Shiekhattar R 2003 Isolation of human NURF: a regulator of Engrailed gene expression. EMBO J 22:6089–7100[CrossRef][Medline]
  56. Bowen NJ, Fujita N, Kajita M, Wade PA 2004 Mi-2/NuRD: multiple complexes for many purposes. Biochim Biophys Acta 1677:52–57[Medline]
  57. Marmorstein R 2001 Protein modules that manipulate histone tails for chromatin regulation. Nat Rev Mol Cell Biol 2:422–432[CrossRef][Medline]
  58. Woodage T, Basrai MA, Baxevanis AD, Hieter P, Collins FS 1997 Characterization of the CHD family of proteins. Proc Natl Acad Sci USA 94:11472–11477[Abstract/Free Full Text]
  59. Toh Y, Pencil SD, Nicolson GL 1994 A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J Biol Chem 269:22958–22963[Abstract/Free Full Text]
  60. Fujita N, Jaye DL, Kajita M, Geigerman C, Moreno CS, Wade PA 2003 MTA3, a Mi-2/NuRD complex subunit, regulates an invasive growth pathway in breast cancer. Cell 113:207–219[CrossRef][Medline]
  61. Shen X, Mizuguchi G, Hamiche A, Wu C 2000 A chromatin remodelling complex involved in transcription and DNA processing. Nature 406:541–544[CrossRef][Medline]
  62. Mizuguchi G, Shen X, Landry J, Wu WH, Sen S, Wu C 2004 ATP-driven exchange of histone H2AZ variant catalyzed by SWR1 chromatin remodeling complex. Science 303:343–348[Abstract/Free Full Text]
  63. Morrison AJ, Highland J, Krogan NJ, Arbel-Eden A, Greenblatt JF, Haber JE, Shen X 2004 INO80 and {gamma}-H2AX interaction links ATP-dependent chromatin remodeling to DNA damage repair. Cell 119:767–775[CrossRef][Medline]
  64. Meneghini MD, Wu M, Madhani HD 2003 Conserved histone variant H2A.Z protects euchromatin from the ectopic spread of silent heterochromatin. Cell 112:725–736[CrossRef][Medline]
  65. Yoshinaga SK, Peterson CL, Herskowitz I, Yamamoto KR 1992 Roles of SWI1, SWI2, and SWI3 proteins for transcriptional enhancement by steroid receptors. Science 258:1598–1604[Abstract/Free Full Text]
  66. Fryer CJ, Archer TK 1998 Chromatin remodelling by the glucocorticoid receptor requires the BRG1 complex. Nature 393:88–91[CrossRef][Medline]
  67. Richard-Foy H, Hager GL 1987 Sequence-specific positioning of nucleosomes over the steroid-inducible MMTV promoter. EMBO J 6:2321–2328[Medline]
  68. Archer TK, Cordingley MG, Wolford RG, Hager GL 1991 Transcription factor access is mediated by accurately positioned nucleosomes on the mouse mammary tumor virus promoter. Mol Cell Biol 11:688–698[Abstract/Free Full Text]
  69. Archer TK, Lefebvre P, Wolford RG, Hager GL 1992 Transcription factor loading on the MMTV promoter: a bimodal mechanism for promoter activation. Science 255:1573–1576[Abstract/Free Full Text]
  70. Hebbar PB, Archer TK 2003 Chromatin remodeling by nuclear receptors. Chromosoma 111:495–504[Medline]
  71. Lee HL, Archer TK 1994 Nucleosome-mediated disruption of transcription factor-chromatin initiation complexes at the mouse mammary tumor virus long terminal repeat in vivo. Mol Cell Biol 14:32–41[Abstract/Free Full Text]
  72. Hebbar PB, Archer TK 2003 Nuclear factor 1 is required for both hormone-dependent chromatin remodeling and transcriptional activation of the mouse mammary tumor virus promoter. Mol Cell Biol 23:887–898[Abstract/Free Full Text]
  73. Nagaich AK, Walker DA, Wolford R, Hager GL 2004 Rapid periodic binding and displacement of the glucocorticoid receptor during chromatin remodeling. Mol Cell 14:163–174[CrossRef][Medline]
  74. McNally JG, Muller WG, Walker D, Wolford R, Hager GL 2000 The glucocorticoid receptor: rapid exchange with regulatory sites in living cells. Science 287:1262–1265[Abstract/Free Full Text]
  75. Wolffe AP, Guschin D 2000 Review: chromatin structural features and targets that regulate transcription. J Struct Biol 129:102–122[CrossRef][Medline]
  76. Aoyagi S, Trotter KW, Archer TK 2005 ATP-dependent chromatin remodeling complexes and their role in nuclear receptor-dependent transcription in vivo. Vitam Horm 70:281–307[CrossRef][Medline]
  77. Hsiao PW, Fryer CJ, Trotter KW, Wang W, Archer TK 2003 BAF60a mediates critical interactions between nuclear receptors and the BRG1 chromatin-remodeling complex for transactivation. Mol Cell Biol 23:6210–6220[Abstract/Free Full Text]
  78. Inoue H, Furukawa T, Giannakopoulos S, Zhou S, King DS, Tanese N 2002 Largest subunits of the human SWI/SNF chromatin-remodeling complex promote transcriptional activation by steroid hormone receptors. J Biol Chem 277:41674–41685[Abstract/Free Full Text]
  79. Fryer CJ, Kinyamu HK, Rogatsky I, Garabedian MJ, Archer TK 2000 Selective activation of the glucocorticoid receptor by steroid antagonists in human breast cancer and osteosarcoma cells. J Biol Chem 275:17771–17777[Abstract/Free Full Text]
  80. Fan HY, Trotter KW, Archer TK, Kingston RE 2005 Swapping function of two chromatin remodeling complexes. Mol Cell 17:805–815[CrossRef][Medline]
  81. Di Croce L, Koop R, Venditti P, Westphal HM, Nightingale KP, Corona DF, Becker PB, Beato M 1999 Two-step synergism between the progesterone receptor and the DNA-binding domain of nuclear factor 1 on MMTV minichromosomes. Mol Cell 4:45–54[CrossRef][Medline]
  82. Li X, Wong J, Tsai SY, Tsai MJ, O’Malley BW 2003 Progesterone and glucocorticoid receptors recruit distinct coactivator complexes and promote distinct patterns of local chromatin modification. Mol Cell Biol 23:3763–3773[Abstract/Free Full Text]
  83. Huang ZQ, Li J, Sachs LM, Cole PA, Wong J 2003 A role for cofactor-cofactor and cofactor-histone interactions in targeting p300, SWI/SNF and Mediator for transcription. EMBO J 22:2146–2155[CrossRef][Medline]
  84. Mymryk JS, Archer TK 1994 Detection of transcription factor binding in vivo using lambda exonuclease. Nucleic Acids Res 22:4344–4345[Free Full Text]
  85. Vicent GP, Nacht AS, Smith CL, Peterson CL, Dimitrov S, Beato M 2004 DNA Instructed Displacement of Histones H2A and H2B at an Inducible Promoter. Mol Cell 16:439–452[CrossRef][Medline]
  86. Sewack GF, Hansen U 1997 Nucleosome positioning and transcription-associated chromatin alterations on the human estrogen-responsive pS2 promoter. J Biol Chem 272:31118–31129[Abstract/Free Full Text]
  87. Giamarchi C, Solanas M, Chailleux C, Augereau P, Vignon F, Rochefort H, Richard-Foy H 1999 Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines. Oncogene 18:533–541[CrossRef][Medline]
  88. Metivier R, Penot G, Hubner MR, Reid G, Brand H, Kos M, Gannon F 2003 Estrogen receptor-{alpha} directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115:751–763[CrossRef][Medline]
  89. Reid G, Hubner MR, Metivier R, Brand H, Denger S, Manu D, Beaudouin J, Ellenberg J, Gannon F 2003 Cyclic, proteasome-mediated turnover of unliganded and liganded ER{alpha} on responsive promoters is an integral feature of estrogen signaling. Mol Cell 11:695–707[CrossRef][Medline]
  90. DiRenzo J, Shang Y, Phelan M, Sif S, Myers M, Kingston R, Brown M 2000 BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol 20:7541–7549[Abstract/